We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,191

Patents in France
  • Casalonga & Associés
  • France, Global
  • March 15 2018

A structured guide to patents law and practice in France

Medicaid Reimbursement and Other Funding Opportunities
  • K&L Gates
  • USA
  • March 1 2018

In the fourth episode of our series on the national opioid crisis, Ruth Granfors and Tracy Lawless discuss how opioid treatment is reimbursed under

Sandoz’s Challenge to Two of AbbVie’s Humira Patents Denied by PTAB
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • February 26 2018

Sandoz’s request for inter partes review (“IPR”) of U.S. Patent Numbers 9,512,216 (“the ’216 patent”) and 8,802,100 (“the ’100 patent”) was denied by

Significant New Medicare, Medicaid, and Other Health Policy and Payment Provisions Adopted in Bipartisan Budget Act
  • Reed Smith LLP
  • USA
  • February 23 2018

The Bipartisan Budget Act of 2018 (the Act), signed into law by President Trump on February 9, 2018, includes extensive and far-reaching Medicare

Recently-Passed CHRONIC Act Allows for Increased Medicare Coverage for Telehealth Services
  • Arent Fox LLP
  • USA
  • February 22 2018

Legislation included as part of the massive congressional budget deal reached earlier this month will pave the way for expanded use of telehealth

Clinical trials in Switzerland
  • Bär & Karrer
  • Switzerland, Global
  • February 22 2018

A structured guide to clinical trials in Switzerland

  • Marshall Gerstein & Borun LLP
  • USA
  • February 21 2018

In re Janssen Biotech, Inc., Appeal 2017-1257 (Fed. Cir. Jan. 23, 2018), is a cautionary tale concerning patents protecting a blockbuster drug

Patentability in Japan
  • SUGIMURA & Partners
  • Global, Japan
  • February 19 2018

A structured guide to patents law and practice in Japan

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong 2018 Start in Biotech Mergers and Acquisitions
  • Knobbe Martens
  • USA
  • February 12 2018

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics

Gene Therapy: Pipeline of Possibilities but Challenges for Pricing
  • Manatt Phelps & Phillips LLP
  • USA
  • January 25 2018

One of the therapeutic areas in development that represents the greatest scientific promise is gene therapy. Gene therapy's potential is